Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sharon Hook

Anatomic Pathology & Clinical Pathology Gainesville, FL Medical Doctor

NPI 1255361911 CMS profile 102461

6500 W Newberry Rd, Gainesville, FL 32605

Open in the dashboard

General payments

$933,856

640 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sharon Hook of Gainesville, FL is reported in the CMS Open Payments database as having received $933,856 across 640 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anatomic Pathology & Clinical Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $136,525 45
2024 General $131,775 40
2023 General $67,620 344
2022 General $110,590 63
2021 General $176,830 59
2020 General $159,274 32
2019 General $151,242 57

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sharon Hook
  • Anatomic Pathology & Clinical Pathology median
  • Middle half of Anatomic Pathology & Clinical Pathology
  • National median

In program year 2025, general payments to Sharon Hook were reported at $136,525. Among 2,804 Anatomic Pathology & Clinical Pathology profiles paid that year, the median was $51 and the middle half received between $24 and $149.

Show as a table
Year Sharon Hook Anatomic Pathology & Clinical Pathology median Middle half National median
2019 $151,242 $65 $22–$150 $163
2020 $159,274 $44 $19–$144 $114
2021 $176,830 $42 $19–$142 $132
2022 $110,590 $54 $20–$140 $149
2023 $67,620 $60 $23–$157 $160
2024 $131,775 $51 $23–$145 $164
2025 $136,525 $51 $24–$149 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $331,700 472 payments
  2. AxoGen $226,207 47 payments
  3. RTI Surgical, Inc $217,529 72 payments
  4. RTI Surgical, Inc. $65,740 17 payments
  5. BioWound Solutions, Inc. $42,000 14 payments
  6. TissueTech, Inc. $28,080 7 payments
  7. Organogenesis Inc. $17,300 10 payments
  8. Merakris Therapeutics, Inc. $5,300 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $602,139 167 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $331,700 472 payments
  3. Food and Beverage $17 1 payment
Products named General payments · program years 2019–2025
  1. Allografts Spine $191,500 101 payments
  2. ALLOGRAFT musculoskeletal $139,910 48 payments
  3. Allografts Spine/Joint $107,500 44 payments
  4. CORTIVA ALLOGRAFT DERMIS $90,580 28 payments
  5. Avance Nerve Graft $86,945 21 payments
  6. ALLOGRAFT musculoskeletal $52,779 13 payments
  7. AXOGUARD NERVE PROTECTOR $50,372 15 payments
  8. AxoGuard Nerve Connector $50,372 15 payments
  9. AXOGUARD NERVE CAP $48,255 13 payments
  10. Axoguard HA+ Nerve Protector $48,255 13 payments
  11. Other $161,200 391 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$64,715

Medicare's payments for the services billed

Medicare patients

622

Average age 74

Services billed

2,136

401 women, 221 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Ischemic heart disease 41%
Diabetes 38%
Chronic kidney disease 35%
Depression 30%
Cancer 28%
Heart failure 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

640 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anatomic Pathology & Clinical Pathology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record